A Real-World Study of Treatment Patterns, Tolerability and Effectiveness of CDK4/6 Inhibition in HR+, HER2-negative Metastatic Breast Cancer Patients
Clinical trial NCT07760714 · COMPLETED
Trial details
- NCT number
- NCT07760714
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2025-02-26
- Primary completion
- 2025-08-29
- Enrollment
- 945
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.